Enzyme Replacement Therapy (ERT) on Heart Function Changes the Outcome in Patients with Infantile-Onset Pompe Disease: A Familial History
Background. Lysosomal acid alpha-glucosidase (GAA) deficiency, also known as Pompe disease, is an autosomal recessive disorder that leads to the accumulation of glycogen in lysosomes and cytoplasm, resulting in tissue destruction. Infantile-onset GAA deficiency is characterized by cardiomyopathy and...
保存先:
主要な著者: | Marco Lecis (著者), Katia Rossi (著者), Maria Elena Guerzoni (著者), Ilaria Mariotti (著者), Lorenzo Iughetti (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
著者:: Lina Fiege, 等
出版事項: (2023) -
Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
著者:: A. D. Dornelles, 等
出版事項: (2024) -
Effect of the enzyme replacement therapy on hypertrophic cardiomyopathy in an infant with the CRIM-negative infantile Pompe's disease
著者:: Guy Vaksmann, 等
出版事項: (2021) -
Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center
著者:: Min-Sun Kim, 等
出版事項: (2019) -
Cognitive Outcome of Infants with Pompe Disease Receiving Enzyme-Replacement Therapy
著者:: J Gordon Millichap
出版事項: (2012)